FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration

Estimated reading time: 1 minutes

• About The Author

FDA approves FluMist for self- or caregiver-administration. FluMist is approved for use in individuals 2 through 49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

About The Author

See author's posts

Trending

Texas events to get you into a Lone Star state of mind